AstraZeneca experiences significant sales growth due to introduction of new drugs

In Uncategorized
The pharmaceutical manufacturer, AstraZeneca, has seen considerable sales growth due to the increased demand in its new drugs during the third quarter, Reuters reports. With sales rising 8% in constant currencies, shares in the group increased 2% in early trading on Thursday (8 November). Sinc...